These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26136457)

  • 1. 15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma.
    Tischler AS; deKrijger RR
    Endocr Relat Cancer; 2015 Aug; 22(4):T123-33. PubMed ID: 26136457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?
    Papathomas TG; Suurd DPD; Pacak K; Tischler AS; Vriens MR; Lam AK; de Krijger RR
    Endocr Pathol; 2021 Mar; 32(1):134-153. PubMed ID: 33433885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Guide to Pheochromocytomas and Paragangliomas.
    Guilmette J; Sadow PM
    Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
    Juhlin CC
    Endocr Pathol; 2021 Jun; 32(2):228-244. PubMed ID: 33768452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and genetics of phaeochromocytoma and paraganglioma.
    Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ
    Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of pheochromocytoma and extra-adrenal paraganglioma.
    Tischler AS; Kimura N; Mcnicol AM
    Ann N Y Acad Sci; 2006 Aug; 1073():557-70. PubMed ID: 17102124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.
    Koh JM; Ahn SH; Kim H; Kim BJ; Sung TY; Kim YH; Hong SJ; Song DE; Lee SH
    PLoS One; 2017; 12(11):e0187398. PubMed ID: 29117221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial pheochromocytomas and paragangliomas.
    King KS; Pacak K
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):92-100. PubMed ID: 23933153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Landscape of Pheochromocytoma and Paraganglioma.
    Jochmanova I; Pacak K
    Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.
    Cascón A; Robledo M
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189141. PubMed ID: 38908536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma and extra-adrenal paraganglioma: updates.
    Tischler AS
    Arch Pathol Lab Med; 2008 Aug; 132(8):1272-84. PubMed ID: 18684026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic basis of pheochromocytoma and paraganglioma: implications for management.
    Shuch B; Ricketts CJ; Metwalli AR; Pacak K; Linehan WM
    Urology; 2014 Jun; 83(6):1225-32. PubMed ID: 24642075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hot Trends in Pheochromocytoma and Paraganglioma: Are We Getting Closer to Personalized Dynamic Prognostication?
    Juhlin CC; Mete O
    Turk Patoloji Derg; 2024; 40(3):143-148. PubMed ID: 39171856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of patients with pediatric pheochromocytoma.
    Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
    Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA flow cytometry in pheochromocytoma and paraganglioma.
    Jung WH; Yang WI; Park C; Choi IJ
    Yonsei Med J; 1992 Sep; 33(3):249-57. PubMed ID: 1292249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Previously Unrecognized Monocytic Component of Pheochromocytoma and Paraganglioma.
    Farhat NA; Powers JF; Shepard-Barry A; Dahia P; Pacak K; Tischler AS
    Endocr Pathol; 2019 Jun; 30(2):90-95. PubMed ID: 31001800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal and extra-adrenal nonfunctioning composite pheochromocytoma/paraganglioma with immunohistochemical ectopic hormone expression: comparison of two cases.
    Gong J; Wang X; Chen X; Chen N; Huang R; Lu C; Chen D; Zeng H; Zhou Q
    Urol Int; 2010; 85(3):368-72. PubMed ID: 20829582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.
    Crona J; Taïeb D; Pacak K
    Endocr Rev; 2017 Dec; 38(6):489-515. PubMed ID: 28938417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
    Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic bases of pheochromocytoma and paraganglioma.
    Cascón A; Calsina B; Monteagudo M; Mellid S; Díaz-Talavera A; Currás-Freixes M; Robledo M
    J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36520714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.